Acciones Beleave Inc. Canadian Securities Exchange
Acciones
BE
CA0775611084
Farmacéuticos
Ventas 2018 | - | Ventas 2019 | 2,37 3,25 2,21 | Capitalización | 30,37 M 41,56 M 28,22 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -12 M -16,42 M -11,15 M | Resultado Neto 2019 | -33 M -45,16 M -30,67 M | VE / Ventas 2018 | - |
Posición de caja neta 2018 | 5,2 M 7,12 M 4,83 M | Deuda neta 2019 | 10,32 M 14,12 M 9,59 M | VE / Ventas 2019 | 17.137.012 x |
P/E ratio 2018 |
-4,72
x | P/E ratio 2019 |
-0,76
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 98,39 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | - | 26/05/00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Founder | - | 26/05/00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+39,33 % | 6114,98 M | |
-18,38 % | 4347,02 M | |
-9,17 % | 3191,44 M | |
+3,98 % | 3152,64 M | |
-3,41 % | 2511,02 M | |
+48,74 % | 1983,16 M | |
-4,82 % | 1737,6 M | |
-1,24 % | 1627,08 M | |
-8,96 % | 1602,33 M |